Symmetron

Symmetron is a well-established boutique consultancy specializing in health economics and health outcomes research. Since 2008, the company has been dedicated to assisting pharmaceutical and healthcare firms in demonstrating and communicating the value of their products, thereby contributing to improved global access to life-saving healthcare. Symmetron offers a comprehensive range of services, including evidence development, health economic modeling, health technology assessment, statistical analysis, scientific writing, training, and workshops, tailored for clients seeking market access and reimbursement across Europe, North America, Asia, and Australia. Over the years, Symmetron has achieved significant success, facilitating the market access of numerous healthcare products and successfully launching several blockbuster pharmaceuticals. With over 100 published scientific articles and an expanding portfolio of core services, it has experienced steady growth driven by the reputation of its exceptional team. Clients consistently praise Symmetron for its team stability, integrity, honesty, transparency, flexibility, agility, pragmatism, professionalism, technical expertise, and partnership approach. These attributes have led to repeat business and referrals, cementing Symmetron's reputation as a trusted and reliable partner in the industry. The company operates in the Health Care and Pharmaceutical sectors and has not disclosed its headquarter location or recent investment details, including investors and funding.